Full Text View
Tabular View
No Study Results Posted
Related Studies
Bradykinin Receptor Antagonism During Cardiopulmonary Bypass- Specific Aim 3 (BRAC)
This study is currently recruiting participants.
Study NCT00223704   Information provided by Vanderbilt University
First Received: September 19, 2005   Last Updated: April 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Arteriosclerosis
Additional conditions recognized in this trial
Arteriosclerosis
Coronary Artery Disease
More general conditions related to this trial
Arterial Occlusive Diseases
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Vascular Diseases
Interventions listed in this trial
HOE 140
Aminocaproic Acid
Placebo
Additional drug interventions recognized in this trial
6-Aminocaproic Acid
Anti-Inflammatory Agents
Antifibrinolytic Agents
Bradykinin
More general drug interventions related to this trial
Cardiovascular Agents
Coagulants
Fibrin Modulating Agents
Hematologic Agents
Hemostatics
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Vanderbilt University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services